Financials

  • Market Capitalization 605.53 M
  • Employee 131
  • Founded 2018
  • CEO Jonathan Drachman M.D.
  • Website www.neurogene.com
  • Headquarter New York, United States
  • FIGI BBG005Y0QDK1
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-4.86
Fiyat/satışlar oranı

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
2784
FBRX
Forte Biosciences, Inc. - Common Stock
44.12 USD+0.46%+113.76%+148.70%+50.32%612.64 M USD
2789
MDXG
MiMedx Group, Inc - Common Stock
4.08 USD-0.73%-0.24%+11.78%-34.82%607.70 M USD
2807
FDMT
4D Molecular Therapeutics, Inc. - Common Stock
11.30 USD-8.20%-11.72%+25.00%0.00%590.72 M USD
2820
ALT
Altimmune, Inc. - Common Stock
2.99 USD-1.97%-2.92%+14.12%-30.30%581.48 M USD

Haberler